STOCK TITAN
  1. Home
  2. Sec-filings
  3. CTKB
  4. [SCHEDULE 13G/A] Cytek Biosciences, Inc. SEC Filing

[SCHEDULE 13G/A] Cytek Biosciences, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CTKB logo
Cytek Biosciences, Inc.

NASDAQ:CTKB

CTKB Rankings

#4217 Ranked by Market Cap
N/A Ranked by Dividends

CTKB Latest News

May 29, 2025
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
May 28, 2025
Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference
May 8, 2025
Cytek Biosciences Reports First Quarter 2025 Financial Results
Apr 29, 2025
Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
Apr 24, 2025
Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

CTKB Latest SEC Filings

Jun 24, 2025
[8-K] Cytek Biosciences, Inc. Reports Material Event
Jun 20, 2025
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity
Jun 20, 2025
[Form 3] Cytek Biosciences, Inc. Initial Statement of Beneficial Ownership
Jun 20, 2025
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Cytek Biosciences, Inc. Insider Trading Activity

CTKB Stock Data

450.91M
114.96M
8.9%
61.33%
2.69%
Medical Devices
Laboratory Analytical Instruments
Link
United States
FREMONT